Table 2 Demographics and clinical characteristics.
Far from onset preHD (N = 12) | Healthy controls (N = 22) | p-value | |
|---|---|---|---|
Sex (male:female) | 3:9 | 15:7 | 0.030a |
Age/y | 36 (32–46), 27–62 | 45 (39–49), 25–51 | 0.287b |
UHDRSb total motor score | 2 (1–3), 0–9 | ||
Years of education | 14 (12–14), 9–17 | 17 (14–18), 12–19 | 0.047b |
CAGn repeat size | 40 (40–42), 39–44 | n/a | n/a |
Disease-burden scored | 202 (169–222), 102–233 | n/a | n/a |
Predicted years to onsete | 23 (19–29), 14–43 | n/a | n/a |
Verbal fluency | 42 (37–50), 30–54 | 41 (33–50), 25–52 | 0.851b |
Stroop color | 80 (62–91), 35–100 | 79 (69–88), 48–96 | 0.808b |
Stroop interference | 55 (44–64), 18–106 | 49 (44–54), 34–65 | 0.359b |
Stroop read | 97 (78–114), 43–128 | 100 (92–134), 74–150 | 0.201b |
SDMTf | 56 (46–67), 25–79 | 53 (50–60), 35–85 | 0.940b |